vs
Doximity, Inc.（DOCS）与IDEAYA Biosciences, Inc.（IDYA）财务数据对比。点击上方公司名可切换其他公司
IDEAYA Biosciences, Inc.的季度营收约是Doximity, Inc.的1.1倍（$207.8M vs $185.1M），IDEAYA Biosciences, Inc.净利率更高（57.4% vs 33.3%，领先24.1%）
Doximity Inc成立于2010年，是面向医疗专业人士的线上社交服务平台，为平台会员提供精选医疗资讯、远程医疗工具，以及病例协作相关功能，助力医疗从业者高效交流信息、开展诊疗相关工作。
IDEAYA Biosciences是一家临床阶段生物技术企业，专注于肿瘤学领域，研发针对基因定义癌症的靶向疗法及合成致死治疗方案，推进多肿瘤类型的候选药物管线开发，与行业伙伴合作提升全球创新癌症治疗方案的可及性。
DOCS vs IDYA — 直观对比
营收规模更大
IDYA
是对方的1.1倍
$185.1M
净利率更高
IDYA
高出24.1%
33.3%
损益表 — Q3 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $185.1M | $207.8M |
| 净利润 | $61.6M | $119.2M |
| 毛利率 | 89.9% | — |
| 营业利润率 | 38.9% | 52.2% |
| 净利率 | 33.3% | 57.4% |
| 营收同比 | 9.8% | — |
| 净利润同比 | -18.1% | 330.1% |
| 每股收益（稀释后） | $0.31 | $1.33 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCSIDYA
| Q4 25 | $185.1M | — | ||
| Q3 25 | $168.5M | $207.8M | ||
| Q2 25 | $145.9M | — | ||
| Q1 25 | $138.3M | — | ||
| Q4 24 | $168.6M | — | ||
| Q3 24 | $136.8M | $0 | ||
| Q2 24 | $126.7M | $0 | ||
| Q1 24 | $118.1M | $0 |
净利润DOCSIDYA
| Q4 25 | $61.6M | — | ||
| Q3 25 | $62.1M | $119.2M | ||
| Q2 25 | $53.3M | — | ||
| Q1 25 | $62.5M | — | ||
| Q4 24 | $75.2M | — | ||
| Q3 24 | $44.2M | $-51.8M | ||
| Q2 24 | $41.4M | $-52.8M | ||
| Q1 24 | $40.6M | $-39.6M |
毛利率DOCSIDYA
| Q4 25 | 89.9% | — | ||
| Q3 25 | 90.3% | — | ||
| Q2 25 | 89.2% | — | ||
| Q1 25 | 89.5% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 90.0% | — | ||
| Q2 24 | 89.3% | — | ||
| Q1 24 | 89.4% | — |
营业利润率DOCSIDYA
| Q4 25 | 38.9% | — | ||
| Q3 25 | 37.8% | 52.2% | ||
| Q2 25 | 37.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 47.4% | — | ||
| Q3 24 | 38.8% | — | ||
| Q2 24 | 36.4% | — | ||
| Q1 24 | 35.5% | — |
净利率DOCSIDYA
| Q4 25 | 33.3% | — | ||
| Q3 25 | 36.8% | 57.4% | ||
| Q2 25 | 36.5% | — | ||
| Q1 25 | 45.2% | — | ||
| Q4 24 | 44.6% | — | ||
| Q3 24 | 32.3% | — | ||
| Q2 24 | 32.7% | — | ||
| Q1 24 | 34.4% | — |
每股收益（稀释后）DOCSIDYA
| Q4 25 | $0.31 | — | ||
| Q3 25 | $0.31 | $1.33 | ||
| Q2 25 | $0.27 | — | ||
| Q1 25 | $0.31 | — | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.22 | $-0.60 | ||
| Q2 24 | $0.21 | $-0.68 | ||
| Q1 24 | $0.20 | $-0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $64.8M | $786.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $979.3M | $1.1B |
| 总资产 | $1.2B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOCSIDYA
| Q4 25 | $64.8M | — | ||
| Q3 25 | $169.2M | $786.9M | ||
| Q2 25 | $137.3M | — | ||
| Q1 25 | $209.6M | — | ||
| Q4 24 | $165.3M | — | ||
| Q3 24 | $184.2M | $920.0M | ||
| Q2 24 | $111.4M | $701.7M | ||
| Q1 24 | $96.8M | $698.8M |
股东权益DOCSIDYA
| Q4 25 | $979.3M | — | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $961.2M | $1.2B | ||
| Q2 24 | $913.6M | $931.7M | ||
| Q1 24 | $901.4M | $935.3M |
总资产DOCSIDYA
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $1.1B | $1.2B | ||
| Q2 24 | $1.1B | $973.7M | ||
| Q1 24 | $1.1B | $961.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.9M | $142.2M |
| 自由现金流经营现金流 - 资本支出 | — | $142.2M |
| 自由现金流率自由现金流/营收 | — | 68.4% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 0.99× | 1.19× |
| 过去12个月自由现金流最近4个季度 | — | $13.5M |
8季度趋势，按日历期对齐
经营现金流DOCSIDYA
| Q4 25 | $60.9M | — | ||
| Q3 25 | $93.9M | $142.2M | ||
| Q2 25 | $62.1M | — | ||
| Q1 25 | $98.5M | — | ||
| Q4 24 | $65.2M | — | ||
| Q3 24 | $68.3M | $-49.2M | ||
| Q2 24 | $41.2M | $-32.9M | ||
| Q1 24 | $63.9M | $-43.8M |
自由现金流DOCSIDYA
| Q4 25 | — | — | ||
| Q3 25 | — | $142.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | — | $-33.9M | ||
| Q1 24 | — | $-45.1M |
自由现金流率DOCSIDYA
| Q4 25 | — | — | ||
| Q3 25 | — | 68.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度DOCSIDYA
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率DOCSIDYA
| Q4 25 | 0.99× | — | ||
| Q3 25 | 1.51× | 1.19× | ||
| Q2 25 | 1.16× | — | ||
| Q1 25 | 1.58× | — | ||
| Q4 24 | 0.87× | — | ||
| Q3 24 | 1.55× | — | ||
| Q2 24 | 1.00× | — | ||
| Q1 24 | 1.57× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOCS
| Subscription | $175.4M | 95% |
| Service Other | $9.7M | 5% |
IDYA
暂无分部数据
